Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BioHarvest Sciences ( (TSE:BHSC) ) just unveiled an update.
BioHarvest Sciences Inc. has announced the voluntary delisting of its common shares from the Canadian Securities Exchange (CSE), while maintaining its listing on the Nasdaq Global Market under the symbol ‘BHST’. This decision is based on the belief that consolidating share trading on Nasdaq will enhance long-term liquidity and shareholder value by eliminating the costs and administrative efforts of dual listing, thereby centralizing its market presence.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, utilizing its patented technology to produce plant-based molecules without growing the plants themselves. The company operates in two main business verticals, offering contract development and production services for complex molecules, and creating proprietary nutraceutical products, such as dietary supplements.
YTD Price Performance: -7.95%
Average Trading Volume: 3,503
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$140.4M
See more insights into BHSC stock on TipRanks’ Stock Analysis page.